STAT News first reported about Prasad’s departure, saying it came after a number of controversial decisions by the FDA regarding a gene therapy drug.
Related Posts
OECD cuts U.S. and global economic outlooks as Trump’s trade tariffs weigh on growth
Global growth is expected to slow from 3.2% in 2024 to 3.1% in 2025 and 3.0% in 2026, according to the OECD.
Why Trump and GOP attacks on IRA can’t score a clean sweep in red states
Not a single Republican voted in favor of Biden’s IRA, but a vow from Trump and a GOP Congress to repeal the act would mean […]
Alphabet to report Q4 earnings after the bell Tuesday
Google is slated to report fourth-quarter earnings on Tuesday after the close of regular trading.